glp-1 obesity drugs news today 2025 Alarming rise in weight loss drug overdoses Study: US obesity rates are

These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers

GLP-1R effects on the vagus nerve can produce a general sense of tiredness

Multiple attempts to delete gspD in several genetic backgrounds failed

Individual results vary, and weight loss depends on dose, diet, activity, and how your body responds

Providers retain full discretion to prescribe or decline compounded GLP-1 medications

When GH levels rise, the liver and other tissues produce more insulin-like growth factor 1 (IGF-1), which mediates many of GHs effects on muscle, recovery, and metabolism